The Genentech Age-related Macular Degeneration (AMD) Research Fellowships offers two grants: basic research in the understanding of AMD and translational AMD research focusing on therapeutics (not yet in clinical trials) Each research fellowship (basic and translational) is $40,000. This award, which was established in 2011, is supported by Genentech through the ARVO Foundation.

Applicant and host information

Applicant citizenship: Any

Host country: United States

Years since PhD: Eligible applicants include newly established investigators who are age 45 or younger at the application deadline and have received their MD, PhD or equivalent degree in past 10 years.

Award details

Award: $40 000

Award Duration (years): 1

Research costs:

Benefits: Funds may be used for research, including salary and benefits

Mobility rule: No

Subjects: Life Sciences , Medicine and Health Sciences

Additional comments: As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. The impact of age-related macular degeneration on the global aging population is enormous as people are deprived of their economic livelihoods and independence. The Genentech Age-related Macular Degeneration (AMD) Research Fellowships offers two grants: (1) basic research in the understanding of AMD and (2) translational AMD research focusing on therapeutics (not yet in clinical trials).

How to apply? For further eligibility requirements and the application process, please visit: Official Funding website


Share this funding

Application deadline

September
We make ensure the accuracy, please refer to the official website for complete details.
Note: This is a community curated project, please contribute/report if any information is missing or not correct. We highly appreciate your contributions!

This entry has been last updated: 2020-05-22 19:13:52

© 2020 ECRcentral. The content is licensed under Creative Commons BY 4.0.
ECRcentral is developed with by eLife Ambassadors.